UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Refinement of breast cancer classification by molecular characterization of histological special types

The Journal of pathology, 2008-10, Vol.216 (2), p.141-150

2008

Link zum Volltext

Verfügbarkeit prüfen

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Oncogene, 2010-04, Vol.29 (14), p.2013-2023

2010

Link zum Volltext

Verfügbarkeit prüfen

A specific gene expression signature for visceral organ metastasis in breast cancer

BMC cancer, 2019-04, Vol.19 (1), p.333-333, Article 333

2019

Link zum Volltext

Verfügbarkeit prüfen

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

Breast cancer research : BCR, 2023-06, Vol.25 (1), p.71-71, Article 71

2023

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.649-659

2019

Link zum Volltext

Verfügbarkeit prüfen

Iatrogenic endometriosis harbors somatic cancer-driver mutations

Human reproduction (Oxford), 2019-01, Vol.34 (1), p.69-78

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer-Associated Mutations in Endometriosis without Cancer

The New England journal of medicine, 2017-05, Vol.376 (19), p.1835-1848

2017

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma

Leukemia, 2014-03, Vol.28 (3), p.719-720

2014

Link zum Volltext

Verfügbarkeit prüfen

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial

Breast (Edinburgh), 2023-08, Vol.70, p.76-81

2023

Link zum Volltext

Verfügbarkeit prüfen

A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity

Oncogene, 2015-01, Vol.34 (4), p.531-536

2015

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites

Blood cancer journal (New York), 2013-09, Vol.3 (9), p.e139-e139

2013

Link zum Volltext

Verfügbarkeit prüfen

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

NPJ breast cancer, 2024-04, Vol.10 (1), p.29-29, Article 29

2024

Link zum Volltext

Verfügbarkeit prüfen

The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy

Virchows Archiv : an international journal of pathology, 2020-10, Vol.477 (4), p.535-544

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

Breast (Edinburgh), 2021-04, Vol.56, p.S61-S62

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of neoadjuvant chemotherapy

Virchows Archiv : an international journal of pathology, 2021-03, Vol.478 (3), p.611-611

2021

Link zum Volltext

Verfügbarkeit prüfen

Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer

NPJ breast cancer, 2022-04, Vol.8 (1), p.56-56, Article 56

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04)

Annals of oncology, 2018-10, Vol.29, p.viii60-viii60

2018

Link zum Volltext

Verfügbarkeit prüfen

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (44), p.18740-18744

2009

Link zum Volltext

Verfügbarkeit prüfen

Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies

Oncogene, 2014-01, Vol.33 (5), p.619-631

2014

Link zum Volltext

Verfügbarkeit prüfen

P57 Value of circulating tumor DNA in the differentiation between malignant and benign ovarian tumors

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A92-A92

2019

Link zum Volltext

Verfügbarkeit prüfen

159 Loss of SIRT2 Confers Resistance to Targeted Therapies

European journal of cancer (1990), 2012-11, Vol.48, p.49-49

2012

Link zum Volltext

Verfügbarkeit prüfen

Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types

British journal of cancer, 2008-12, Vol.99 (11), p.1884-1890

2008

Link zum Volltext

Verfügbarkeit prüfen

A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

Cancer cell, 2007-10, Vol.12 (4), p.395-402

2007

Link zum Volltext

Verfügbarkeit prüfen

1240P Multi-centric validation of an AI-based sTIL% scoring model for breast cancer H&E whole-slide images

Annals of oncology, 2023-10, Vol.34, p.S724-S724

2023

Link zum Volltext

Verfügbarkeit prüfen

474P ctDNA-based copy number dynamics during anti-PD1 treatment in patients with metastatic triple-negative breast cancer

Annals of oncology, 2023-10, Vol.34, p.S380-S380

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Englisch
(149)
Japanisch
(20)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(14)
Cancer Research
(11)
Neuromuscular Disorders : Nmd
(8)
Npj Breast Cancer
(8)
Breast Cancer Research And Treatment
(5)
Neuroscience
(4)
Bmc Cancer
(3)
Breast
(3)
Breast Cancer Research : Bcr
(3)
Cancers
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Refinement of breast cancer classification by molecular characterization of histological special types

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

A specific gene expression signature for visceral organ metastasis in breast cancer

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior

Iatrogenic endometriosis harbors somatic cancer-driver mutations

Cancer-Associated Mutations in Endometriosis without Cancer

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial

A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

Correction to: The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of neoadjuvant chemotherapy

Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer

Tumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04)

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies

P57 Value of circulating tumor DNA in the differentiation between malignant and benign ovarian tumors

159 Loss of SIRT2 Confers Resistance to Targeted Therapies

Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types

A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

1240P Multi-centric validation of an AI-based sTIL% scoring model for breast cancer H&E whole-slide images

474P ctDNA-based copy number dynamics during anti-PD1 treatment in patients with metastatic triple-negative breast cancer

Suchergebnisse filtern